Gene · 8655
DYNLL1: dynein light chain LC8-type 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DYNLL1: dynein light chain LC8-type 1. Genes, record 8655. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8655
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P63167 | Dynein light chain 1, cytoplasmic | 89 | 21 | Ensembl, GeneID, HGNC |
Source UniProt
Patents60
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44496 | P63167 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44497 | P63167 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44498 | P63167 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44499 | P63167 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44501 | P63167 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1064 | P63167 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1064 | P63167 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 26185 | P63167 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 26186 | P63167 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 26187 | P63167 | Espacenet |
1 to 10 of 60
See all 60 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,106
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DYNLL1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P51OD011106 | Wisconsin National Primate Research Center Support | 5 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 3 | 2025 |
| P50AA022537 | Cross-species investigation of gene networks for ethanol-related behaviors | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 3 | 2025 |
| R35GM136414 | The Mechanism and Regulation of the Dynein Transport Machinery | 3 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 2 | 2025 |
1 to 10 of 1,106Source NIH's project files
See all 1,106 nih grantsPapers2,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond membrane transport: Transporters as dynamic signal integrators for plant signaling and adaptation. | Plant Commun | 2026 | 42675857 | PubTator, text mining | PubMed |
| Walking the tightrope: Balancing opposing cooperativities in dynein assembly. | J Biol Chem | 2026 | 42586425 | PubTator, text mining | PubMed |
| Boron-bridged GIPCs stabilize cell wall anchoring and PIN polar domains. | Cell | 2026 | 42462711 | PubTator, text mining | PubMed |
| Small Peptides, Smart Plants: The Emerging Significance of SCOOP Signalling. | Plant Cell Environ | 2026 | 42186853 | PubTator, text mining | PubMed |
| Walking the Tightrope: Balancing Opposing Cooperativities as an Operating Principle in Dynein Assembly. | bioRxiv | 2026 | 42146451 | PubTator, text mining | PubMed |
| Comparing perceptions of users on digital authentication through one-time passcode, fingerprint, voice recognition, PIN code, finger swipe, and authentication of choice: A cross-sectional survey. | PLoS One | 2026 | 41920804 | PubTator, text mining | PubMed |
| Identification of DYNLL1 and FGFR2 as potential apoptosis-associated biomarkers in HBV-related hepatocellular carcinoma. | Discov Oncol | 2026 | 41910869 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Multiple data set Bayesian analysis synergistically boosts ITC parameter precision. | Biophys J | 2026 | 41852030 | PubTator, text mining | PubMed |
| NMD takes two PIN domains to tango. | RNA | 2026 | 41813061 | PubTator, text mining | PubMed |
1 to 10 of 2,043
See all 2,043 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8655
GET https://conductscience.org/api/genes/v1/8655/patents?page=2